ArticleBMC biology2025
Accurate prediction of drug-protein interactions by maintaining the original topological relationships among embeddings.
Article in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- AMCF-RDP: a self-attention-based multi-source and cascade framework for the identification of drug-protein relationships.Molecular diversity · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundLearning-based methods have recently demonstrated strong potential in predicting drug-protein interactions (DPIs). However, existing approaches often fail to achieve accurate predictions on real-world imbalanced datasets while maintaining high generalizability and scalability, limiting their practical applicability.
resultsThis study proposes a highly generalized model, GLDPI, aimed at improving prediction accuracy in imbalanced scenarios by preserving the topological relationships among initial molecular representations in the embedding space. Specifically, GLDPI employs dedicated encoders to transform one-dimensional sequence information of drugs and proteins into embedding representations and efficiently calculates the likelihood of DPIs using cosine similarity. Additionally, we introduce a prior loss function based on the guilt-by-association principle to ensure that the topology of the embedding space aligns with the structure of the initial drug-protein network. This design enables GLDPI to effectively capture network relationships and key features of molecular interactions, thereby significantly enhancing predictive performance.
conclusionsExperimental results highlight GLDPI's superior performance on multiple highly imbalanced benchmark datasets, achieving over a 100% improvement in the AUPR metric compared to state-of-the-art methods. Additionally, GLDPI demonstrates exceptional generalization capabilities in cold-start experiments, excelling in predicting novel drug-protein interactions. Furthermore, the model exhibits remarkable scalability, efficiently inferring approximately
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.